India’s drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Light, while ruling out the need for the conduct of the phase-3 trial of the Russian vaccine in the country.
According to the recommendations of the Subject Expert Committee (SEC) meeting held on
India believes there is an urgent need for carrying out “major reforms” in the World Health Organization to ensure a timely, focused and effective response to potential future pandemics, Union Health Minister Harsh Vardhan said on Wednesday.
Speaking at a meeting of the health ministers of
Individual member states of the European Union will have the option to accept vaccines authorised by the World Health Organisation (WHO) like Covishield for obtaining the bloc’s digital COVID certificate or ‘Green Pass’, an EU official said on Tuesday.
The official said the European Medicines Agency
India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US’ National Institute of Health has said. The NIH said results of two studies of blood serum from people who
The second Covid wave has led to children across age groups falling prey to psychological issues due to increased screen time, no social interaction and parents not having time for them despite working from home, experts have said.
Dr Meena J, Paediatrician, Aakash Healthcare, Dwarka, said
A third shot of the Oxford-AstraZeneca COVID-19 vaccine produces a strong immune response, researchers said on Monday, adding there was not yet evidence that such shots were needed, especially given shortages in some countries. The Oxford University study found that a third dose of the
The Navi Mumbai Municipal Corporation, which recently undertook a drive to vaccinate homeless persons and beggars against COVID-19, has now started a campaign to inoculate potential super-spreaders in the township, a civic official said on Monday. In the first phase of the new campaign, 250
India has the capacity to store vaccines that may require a lower temperature in the range of minus 15 to minus 20 degrees Celsius and there are over 29,000 cold chain points (CCPs) across the country where vaccines are stored at the recommended temperatures, the
Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its COVID-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection.
A third wave of COVID-19 — if it occurs — is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study. The study, based on mathematical